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    Recently， combination chemotherapy of bleomycin， vinblastine and cis－dichlorodiarnineplatinum
has dramatically advanced the treatment of metastatic testicular tumors． However， we believe that
solid malignant tumors should be reduced surgically as much as possible．
   Twelve patients underwent surgery to resect a bulky metastatic mass of testicular tu皿or in the
retroperitoneum 4 to 36 days（average，18 days）after begi皿ing combination che皿otherapy or ir－
radiatibh． ”The bulky tUm6rs’ wefe successfu’liy’ resected in all patients except one who underwent
partial resection． Resected tumors were 59 g on the average （20一一170 g）． Surgery lasted for an
average of 4 hours 20 minutes （2 hours 40 minutestv6 hours 30 minutes）． As combined surgery， ．
1 patient had nephrectomy， 1 patient had parti’al gastrectomy， 2 patients had resection ofsupraclavicular
metastatic tumors and 1 patient had vena cava inferior removed． Mesenteric inferior artery was
ligated in 7 patients， 2 of whom complained ofsevere diarrhea for 7 days postoperatively． Postoperative
complications were ileus in 2 patients， hydronephrosis in 1 patient and loss of emission in 5 patients．
   With additiona1 combination chemotherapy and irradiation following the reductive surgery，
10 patients （830／o） with seminoma， embryonal carcinoma or teratoma immature have been continuously
free of disease for 13一一56 months （average， 28 months）， one patient with reticulum cell sarcoma died
of sepsis due to chemotherapy at 9 months after reductive surgery and the last patient with embryonal
carcinoma and seminoma is alive although in partial remission of lung metastasis at 3 months after
surgery．
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Tumor clinically limited to the testis
Clinical or radiographic evidence of
tumor beyond亡he testicle bu亡limited
to the regienal lymphatics below the
diaphragm； excluding massive retro－
peritoneal disease
Retroperitoneal lymphatic disease
greater than 15 cm in diameter
（Bulky Tumor）
    beyond the diaphragm
but still confined to the metiastinal
or supraclavicular lymphatics































Table 2． Treatment planning of advanced testicular cancer
｝．Orchiec十〇my with high ligotion
2， Linac 1500－2000 rad． to para－ortic orea or BV
 therapy or BPV theropy
        l 25456789101112 15 14 doy
l鼎蹴∵轡…“〕㌔
3．Reductive surgery for me†os十atic tes十icular†umor
 in retroperltoneum
4． Linac 1500－5000 rad， to para－aortic area
5， BPV therapy 1－4 courses
6． Maintenance chernotheropy of BV theropy every 5




Fig． 1． lncision in the posterior parietal periton－
    eum over the bulky tumor and for testi－






























Fig． 2． Suda’s forcep used at retroperitoneal






























Table 3． Reductive surgery for metastatic bulky tumor in retroperitoneum























































































6． M，Y． 40 ls
7． H，Y． 24 rs
8． T．T． 28 rs
9， HM 43［s
IO． T．H． 17 ］s
11． NM rs rs















































































Average 29．8 18 doys 4。20ノ 920 59
＊ S：Seminoma， E：Embryonol carcinoma，

































































（一）．ll月1日よりcis－Pt 36 m9×5日， BLM 30















た．3月26日よりcis－Pt 37 mg 5日連続投与， VBL






































Fig． 5． lnferior venacavography of case No 8．See
    thro皿bus ln rlght lllac velns and aberrant
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